Search results for " effect"

showing 10 items of 7524 documents

Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ -

2014

Objectives: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a relatively rare but serious side effect of bisphosphonate (BP)-based treatments. This retrospective study aimed to investigate the risk factors and predictive markers in cases where patients were refractory to a recommended conservative treatment offered in our hospital. Patients and Methods: This single-center study collated the medical records of all patients treated for BRONJ between 2004 and 2011. A complete medical history, including detailed questionnaires, was collected for all patients, focusing on identifying underlying risk factors, clinical features, location and bone marker levels of BRONJ. Results: The mea…

medicine.medical_specialtySide effectbusiness.industryMedical recordmedicine.medical_treatmentResearchRetrospective cohort studyOdontologíaBisphosphonatemedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryN-terminal telopeptideInternal medicineUNESCO::CIENCIAS MÉDICASMedicineMedical historyOral SurgerybusinessOsteonecrosis of the jawGeneral DentistryProgressive disease
researchProduct

Fluorescein for resection of high-grade gliomas: A safety study control in a single center and review of the literature

2017

Background: The importance of a complete resection of high-grade gliomas (HGGs) has been highlighted in scientific literature, in order to limit tumor recurrence and above all to improve disease-free survival rates. Several fluorescent biomarkers have been tested to improve intraoperative identification of residual tumor; 5-aminolevulinic acid (5-ALA) and fluorescein sodium (FS) are now starting to play a central role in glioma surgery. We performed a retrospective analysis on 47 patients operated for HGGs. Here we report our preliminary data. Methods: Data of 47 consecutive patients with HGG have been collected in our study (25 males, 22 females; mean age: 60.3 years, range: 27-86 years). …

medicine.medical_specialtySingle CenterResection03 medical and health scienceschemistry.chemical_compound0302 clinical medicineGliomaYELLOW 560 filterMedicinefluorescein sodiumFluoresceinAdverse effectSettore MED/27 - Neurochirurgiabusiness.industrySubtotal ResectionPartial resectionmedicine.diseaseextent of resectionSurgerychemistry5-aminolevulinic acid030220 oncology & carcinogenesisSurgeryNeuro-Oncology: Original ArticleNeurology (clinical)Sodium fluoresceinbusinessNuclear medicinehigh-grade gliomas030217 neurology & neurosurgerySurgical Neurology International
researchProduct

A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor-5 coated onto β-tricalcium ph…

2010

Objectives: The aim of this prospective, randomized clinical trial was to investigate the potential of recombinant human growth and differentiation factor-5 (rhGDF-5) coated onto β-tricalcium phosphate (β-TCP) (rhGDF-5/β-TCP) to support bone formation after sinus lift augmentation. Material and methods: In total, 31 patients participated in this multicenter clinical trial. They required a two-stage unilateral maxillary sinus floor augmentation (residual bone height <5 mm). According to a parallel-group design, the patients were randomized to three treatment groups: (a) augmentation with rhGDF-5/β-TCP and a 3-month healing period, (b) augmentation with rhGDF-5/β-TCP and a 4-month healing per…

medicine.medical_specialtySinus Floor AugmentationMaxillary sinusbusiness.industrySinus liftImplant failureSurgerylaw.inventionClinical trialmedicine.anatomical_structureTrephineRandomized controlled triallawMedicineOral SurgerybusinessAdverse effectClinical Oral Implants Research
researchProduct

Health literacy of patients on oral anticoagulation treatment- individual and social determinants and effect on health and treatment outcomes

2021

Abstract Background Assessment health literacy in people with cardiovascular health problems would facilitate the development of appropriate health strategies for the care and reduction of complications associated with oral anticoagulation therapy. Aim: To evaluate the relationship between health literacy and health and treatment outcomes (concordance with oral anticoagulants, Normalized Ratio control and occurrence of complications) in patients with cardiovascular pathology. Methods Observational, analytic and cross-sectional study carried out on 252 patients with cardiovascular pathology (atrial fibrillation, flutter or valve prosthesis), aged 50–85 years, accessing primary care services …

medicine.medical_specialtySocial Determinants of HealthAdministration OralHealth literacy030204 cardiovascular system & hematologyRT1117 Public Health and Health ServicesTreatment adherence and compliance03 medical and health sciences0302 clinical medicineRA0421Atrial FibrillationEpidemiologySelf-managementmedicineHumansSalutAlfabetització030212 general & internal medicineSocial determinants of healthPublic Environmental & Occupational HealthDrug-related side effects and adverse reactionPolypharmacyAcenocoumarolScience & Technologybusiness.industryAcenocoumarolPublic healthPublic Health Environmental and Occupational HealthHealth literacyAnticoagulantsCAREHealth servicesCross-Sectional StudiesTreatment OutcomeSpainEmergency medicineHEART-FAILUREObservational studyPublic HealthPublic aspects of medicineRA1-1270BiostatisticsbusinessLife Sciences & BiomedicineResearch Articlemedicine.drugBMC Public Health
researchProduct

Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy.

2015

Objective:Across Italy up to 7.3% of the population is infected with hepatitis C virus (HCV), with long-term complications resulting in high medical costs and significant morbidity and mortality. Current treatment options have limitations due to side effects, interferon intolerability and ineligibility, long treatment durations and low sustained virological response (SVR) rates, especially for the most severe patients). Sofosbuvir is the first nucleotide polymerase inhibitor with pan-genotypic activity. Sofosbuvir, administered with ribavirin (RBV) and with or without pegylated interferon (PEG-INF), resulted in &gt;90% SVR across treatment-naïve (TN) genotype (GT) 1-6 patients. It is also t…

medicine.medical_specialtySofosbuvirGenotypeCost effectivenessHepatitis C virusCost-Benefit AnalysisAlpha interferonmedicine.disease_causeGastroenterologyPolyethylene GlycolAntiviral AgentsSeverity of Illness IndexTelaprevirTelaprevirPolyethylene Glycolschemistry.chemical_compoundPegylated interferonBoceprevirInternal medicineQuality-Adjusted Life YearRibavirinmedicineCost-effectiveness analysiHumansCost-Benefit AnalysiAntiviral AgentBoceprevirbusiness.industryHealth PolicyRibavirinInterferon-alphaMarkov ChainHepatitis C ChronicPatient Acceptance of Health CareVirologyChronic hepatitis C infectionMarkov ChainschemistryItalyDrug Therapy CombinationQuality-Adjusted Life YearsSofosbuvirbusinessmedicine.drugHumanJournal of medical economics
researchProduct

Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests

2007

Many problems such as non-response, pharmacokinetic interactions with clinical consequences and adverse effects (pharmacovigilance) may be observed in patients submitted to psychopharmacotherapy. These risks are increased in patients belonging to the category of “special populations”: elderly patients, children and adolescents, patients with a genetic particularity of metabolism or suffering from somatic or psychic comorbidities. Pharmacokinetic and pharmacogenetic tests are useful to solve problems in psychopharmacotherapy and thus improve efficacy and safety. Therapeutic drug monitoring (TDM) is particularly recommended in situations presented above and in patients who are non-compliant. …

medicine.medical_specialtySpecial populationsmedicine.diagnostic_testbusiness.industryTreatment outcomePsychiatry and Mental healthPharmacokineticsTherapeutic drug monitoringPharmacovigilancemedicineIn patientIntensive care medicinebusinessAdverse effectPharmacogeneticsEuropean Psychiatry
researchProduct

Online Adaptation to Altered Auditory Feedback Is Predicted by Auditory Acuity and Not by Domain-General Executive Control Resources

2018

Published: 12 March 2018 When a speaker's auditory feedback is altered, he adapts for the perturbation by altering his own production, which demonstrates the role of auditory feedback in speech motor control. In the present study, we explored the role of auditory acuity and executive control in this process. Based on the DIVA model and the major cognitive control models, we expected that higher auditory acuity, and better executive control skills would predict larger adaptation to the alteration. Thirty-six Spanish native speakers performed an altered auditory feedback experiment, executive control (numerical Stroop, Simon and Flanker) tasks, and auditory acuity tasks (loudness, pitch, and …

medicine.medical_specialtySpeech productionauditory acuityspeech productionadaptationAudiologyta311201 natural sciences050105 experimental psychologylcsh:RC321-571LoudnessBehavioral Neurosciencepuheentuotto0103 physical sciencesOnline adaptationmedicine0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. Neuropsychiatry010301 acousticsaltered feedbackBiological PsychiatryOriginal ResearchAuditory acuityAuditory feedbackpalaute05 social sciencesCognitionPseudowordPsychiatry and Mental healthexecutive controlNeuropsychology and Physiological PsychologyNeurologyPsychologyNeuroscienceStroop effectFrontiers in Human Neuroscience
researchProduct

Lift weights to fight overweight

2014

Although resistance training (RT) has long been accepted as a means for developing and maintaining muscular strength, endurance, power and muscle mass, its beneficial relationship with health factors and chronic disease has only recently been recognized in the scientific literature. Prior to 1990, resistance training was not a part of the recommended guidelines for exercise training and rehabilitation for either the American Heart Association or the American College of Sports Medicine (ACSM). In 1990, the ACSM recognized resistance training as a significant component of a comprehensive fitness programme for healthy adults of all ages, a position subsequently confirmed few years after. At pr…

medicine.medical_specialtySports medicinePhysiologymedicine.medical_treatmentOverweightweight controlMuscle massPhysical strengthModels BiologicalBody Mass IndexPhysiology (medical)medicineHumansoverweightEvidence-Based MedicineRehabilitationexercisebusiness.industryexcess postexercise oxygen consumptionResistance trainingGeneral MedicineWeight controlTreatment OutcomePhysical FitnessMetabolic effectsPhysical therapyresistance trainingmedicine.symptomEnergy MetabolismbusinessmetabolismClinical Physiology and Functional Imaging
researchProduct

Clinical review: impact of statin substitution policies on patient outcomes.

2009

Background. The increasing awareness of cost issues in health care has led to the increasing use of policy-driven substitution of branded for generic medications, particularly relative to statin treatment for cardiovascular diseases. While there are potential short-term health care savings, the consequences for primary care are under-researched. Our objective was to review data on intensive statin therapy and generic substitution in patients at high cardiovascular risk. Results. Current treatment guidelines for the prevention of cardiovascular disease are consistent in their recommendations regarding statin therapy and treatment targets. Clinical trials demonstrate that to reduce cardiovasc…

medicine.medical_specialtyStatinCost effectivenessmedicine.drug_classDiseasePlaceboReimbursement MechanismsRisk FactorsHealth caremedicineDrugs GenericHumanscardiovascular diseasesIntensive care medicinebusiness.industryPublic healthHealth Policynutritional and metabolic diseasesGeneral MedicineClinical trialEuropeCardiovascular DiseasesPractice Guidelines as TopicPhysical therapyObservational studylipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitorsbusiness
researchProduct

Statin intolerance: new data and further options for treatment

2021

Purpose of review Hypercholesterolemia is a major risk factor for cardiovascular diseases. Administration of statins represents the cornerstone of the prevention and treatment of cardiovascular disease, with demonstrated long-term safety and efficacy. This review aims to revisit statin intolerance mechanisms, as well as to discuss new data and therapeutic options. Recent findings Although statins are well tolerated, myopathy and other adverse effects are a challenging problem, being the main reason for poor adherence to treatment and failure in lowering cardiovascular risk. Statin intolerance is the subject of ongoing research, as these drugs are widely used. There are alternative options o…

medicine.medical_specialtyStatinDosemedicine.drug_classHypercholesterolemiaDisease030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEzetimibeHumansMedicinecardiovascular diseases030212 general & internal medicineRisk factorIntensive care medicineAdverse effectbusiness.industryCholesterolAnticholesteremic Agentsangiopoietin-like 3 protein inhibitors bempedoic acid ezetimibe proprotein convertase subtilisin-kexin type 9 inhibitors statin intolerance Cholesterol LDL Ezetimibe Humans Proprotein Convertase 9 Anticholesteremic Agents Cardiovascular Diseases Hydroxymethylglutaryl-CoA Reductase Inhibitors Hypercholesterolemianutritional and metabolic diseasesCholesterol LDLEzetimibeRegimenchemistryCardiovascular Diseaseslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsProprotein Convertase 9Cardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct